Assessment of Hepatitis C Virus (HCV) recurrence impact on the patient and survival after liver transplantation.
Awad, H., abdel Wahab, M., Shehatta, A., Elkhawaga, O. (2024). Assessment of Hepatitis C Virus (HCV) recurrence impact on the patient and survival after liver transplantation.. EKB Journal Management System, 64(1), 12-17. doi: 10.21608/mjcc.2024.411378
Hanan S. Awad; Mohmed abdel Wahab; Ahmed S. Shehatta; Omali Elkhawaga. "Assessment of Hepatitis C Virus (HCV) recurrence impact on the patient and survival after liver transplantation.". EKB Journal Management System, 64, 1, 2024, 12-17. doi: 10.21608/mjcc.2024.411378
Awad, H., abdel Wahab, M., Shehatta, A., Elkhawaga, O. (2024). 'Assessment of Hepatitis C Virus (HCV) recurrence impact on the patient and survival after liver transplantation.', EKB Journal Management System, 64(1), pp. 12-17. doi: 10.21608/mjcc.2024.411378
Awad, H., abdel Wahab, M., Shehatta, A., Elkhawaga, O. Assessment of Hepatitis C Virus (HCV) recurrence impact on the patient and survival after liver transplantation.. EKB Journal Management System, 2024; 64(1): 12-17. doi: 10.21608/mjcc.2024.411378

Assessment of Hepatitis C Virus (HCV) recurrence impact on the patient and survival after liver transplantation.

Mansoura Journal of Chemistry
Volume 64, Issue 1, January 2024, Page 12-17  XML PDF (876.76 K)
Document Type: Original Article
DOI: 10.21608/mjcc.2024.411378
View on SCiNiTO View on SCiNiTO
Authors
Hanan S. Awad* 1; Mohmed abdel Wahab2; Ahmed S. Shehatta2; Omali Elkhawaga1
1Chemistry department, Faculty of Science, Mansoura University
2Gastro Intestinal Surgery Center, Faculty of Medicine, Mansoura University, Egypt
Abstract
Hepatitis C virus (HCV) related liver disease is the primary cause of cirrhosis and hepatocellular carcinoma (HCC) globally, leading to liver transplantation (LT). Although LT effectively reduces morbidity and mortality, patients with HCV-related end-stage liver disease inevitably face universal re-infection of the transplanted liver. When viral RNA is detectable during LT, HCV re-infection occurs, causing chronic hepatitis in at least 50% of grafts after one year and up to 100% after five years. This study aimed to identify HCV development risk factors and assess the consequences of HCV recurrence post-LT on patients and transplanted livers. The research involved 37 LDLT patients (18-65 years old) and 30 healthy individuals, measuring serum HCV-RNA and biochemical parameters. Results showed HCV recurrence in 32.4% and 45.9% after 3 and 6 months post-LT, respectively, compared to the control group. There was a significant difference in biochemical parameters between recurrence and non-recurrence patients. Despite achieving sustained virologic response (SVR) before LT, recurrent HCV becomes more pronounced three months post-LT, negatively impacting both graft and patient survival, with a substantial portion experiencing significant liver damage after LT.
Keywords
Living donor; liver transplantation (LDLT); HCV infection; recurrence
Statistics
Article View: 67
PDF Download: 23